Log In | Register
Lechleiter inherits the biggest problem facing Big Pharma today: beefing up the pipeline in the face of disappearing blockbusters. And having been an industry insider for nearly 30 years, he understands as well as anyone it's like playing the lottery, with a fat pay-off but long odds.
{"contentId":"1396521","authorDomain":"dojc"}
Lechleiter takes Lilly Top Job
News Type: Event — Seeded on Fri Mar 28, 2008 1:48 PM EDT
Article Source: CNN
 | Lilly Settles Alaska Suit Over Zyprexa | Associated Press | Wed Mar 26 | 0 |
| New Eli Lilly CEO Walks Into Tough Road | Associated Press | Sun Mar 30 | 0 |
{"contentId":"1396521","authorDomain":"dojc"}
- Enjoy this article? Help vote it up the 'Vine.
- Public Discussion (0)
{"canLink":false,"threadId":0,"isPrivate":false}
You're in Easy Mode. If you prefer, you can use XHTML Mode instead. |
As a new user, you may notice a few temporary content restrictions. Click here for more info.
Start Tracking
Stop Tracking